XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
160 hedge funds and large institutions have $1.03B invested in Intersect ENT, Inc in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 26 closing their positions.
Holders
160
Holders Change
-12
Holders Change %
-6.98%
% of All Funds
3.67%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
67
Reduced
50
Closed
26
Calls
$6.19M
Puts
$3.41M
Net Calls
+$2.78M
Net Calls Change
+$1.06M
Top Buyers
| 1 |
HM
1
HealthCor Management
New York
|
$47.5M |
| 2 |
2
Westfield Capital Management
Boston,
Massachusetts
|
$17.3M |
| 3 |
O
3
OppenheimerFunds
New York
|
$14.9M |
| 4 |
4
BlackRock
New York
|
$86.5M |
| 5 |
5
Loomis, Sayles & Company
Boston,
Massachusetts
|
$20.3M |
